Cargando…
Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)
Pancreatic cancer (PC) has one of the highest fatality rates and the currently available therapeutic options are not sufficient to improve its overall poor prognosis. In addition to insufficient effectiveness of anticancer treatments, the lack of clear early symptoms and early metastatic spread main...
Autores principales: | Zuzčák, Michal, Trnka, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256076/ https://www.ncbi.nlm.nih.gov/pubmed/35730611 http://dx.doi.org/10.3892/ijo.2022.5383 |
Ejemplares similares
-
Low Glucose but Not Galactose Enhances Oxidative Mitochondrial Metabolism in C2C12 Myoblasts and Myotubes
por: Elkalaf, Moustafa, et al.
Publicado: (2013) -
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer
por: Shimazaki, Reiri, et al.
Publicado: (2021) -
Computational Model Predicts the Effects of Targeting Cellular Metabolism in Pancreatic Cancer
por: Roy, Mahua, et al.
Publicado: (2017) -
Type 3 inositol 1,4,5-trisphosphate receptor has antiapoptotic and proliferative role in cancer cells
por: Rezuchova, Ingeborg, et al.
Publicado: (2019) -
Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy
por: Khan, Husain Yar, et al.
Publicado: (2022)